Prevention of developmental delays in a Down syndrome mouse model.
about
Prospects for Improving Brain Function in Individuals with Down SyndromeTiming of therapies for Down syndrome: the sooner, the betterMouse models of Down syndrome as a tool to unravel the causes of mental disabilitiesEffects of neonatal neural progenitor cell implantation on adult neuroanatomy and cognition in the Ts65Dn model of Down syndromeMolecular basis of pharmacotherapies for cognition in Down syndromePrenatal treatment prevents learning deficit in Down syndrome model.Down syndrome--recent progress and future prospects.Neuroprotective fractalkine in fetal alcohol syndrome.Sera from children with autism induce autistic features which can be rescued with a CNTF small peptide mimetic in ratsChronic P7C3 treatment restores hippocampal neurogenesis in the Ts65Dn mouse model of Down Syndrome [Corrected].Molecular and cellular alterations in Down syndrome: toward the identification of targets for therapeuticsAbsence of Prenatal Forebrain Defects in the Dp(16)1Yey/+ Mouse Model of Down Syndrome.Down syndrome and the molecular pathogenesis resulting from trisomy of human chromosome 21.Early neurotrophic pharmacotherapy rescues developmental delay and Alzheimer's-like memory deficits in the Ts65Dn mouse model of Down syndrome.Is it possible to improve neurodevelopmental abnormalities in Down syndrome?Potential Role of Microtubule Stabilizing Agents in Neurodevelopmental Disorders.Cognitive and pharmacological insights from the Ts65Dn mouse model of Down syndromeLongitudinal measures of cognition in the Ts65Dn mouse: Refining windows and defining modalities for therapeutic intervention in Down syndrome.
P2860
Q22252566-0D3A1BDC-F394-4301-8429-F45727500776Q26779297-3221147B-32F3-432A-9E52-966DB8261F7BQ26863005-7942FBE3-1EF3-4BE0-A1C5-8E1658D45524Q27303804-EBE9D907-6AA3-41E1-BEAA-F24B10F36C1AQ33625613-3B0BE9F7-A0DD-4412-8AAD-B7355D5428DCQ34500663-73CBD901-2B13-4B51-AC6F-4BE4469ACCB3Q34964947-42569C13-2FCA-481A-A5C2-FE4EA7E542DFQ34976523-68CBFDDF-511F-4B70-A8AC-D8E3902D1B99Q35175633-E2D2E85C-F915-4F60-A84F-B5C54C4355DCQ35187108-36DA9BE7-A335-49D5-B683-3870E57E18F0Q36111546-17173B0C-F53A-4948-8638-BBB401A3730AQ36665885-9863BAF7-02D5-4A64-A39E-FBC96960D9F4Q36681400-C6E14F29-270E-498B-B219-5EE5C015852AQ37734742-21C39C2F-36B4-4431-AD05-3A1FF8B4576DQ37912174-95C40954-4CF4-4B15-B8DD-643D065F1D2DQ41573058-255BA342-B4C8-4EA2-A9F7-A0A6B2506EF7Q41811378-769D7391-665F-481F-8011-DED5050001F2Q47151363-745E1F07-708F-49C5-8AED-DCA4029A3325
P2860
Prevention of developmental delays in a Down syndrome mouse model.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Prevention of developmental delays in a Down syndrome mouse model.
@en
Prevention of developmental delays in a Down syndrome mouse model.
@nl
type
label
Prevention of developmental delays in a Down syndrome mouse model.
@en
Prevention of developmental delays in a Down syndrome mouse model.
@nl
prefLabel
Prevention of developmental delays in a Down syndrome mouse model.
@en
Prevention of developmental delays in a Down syndrome mouse model.
@nl
P2093
P2860
P1476
Prevention of developmental delays in a Down syndrome mouse model.
@en
P2093
Daniel Abebe
Irene Cameroni
Laura Toso
Robin Roberson
Stephanie Bissell
P2860
P304
P356
10.1097/AOG.0B013E31818C91DC
P407
P577
2008-12-01T00:00:00Z